-
公开(公告)号：US12229957B2
公开(公告)日：2025-02-18
申请号：US18307316
申请日：2023-04-26
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , David S. Paik
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US11676359B2
公开(公告)日：2023-06-13
申请号：US17328414
申请日：2021-05-24
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
IPC: G06T7/00 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/00 , G06K9/62 , G06T3/00 , G06V10/25 , G06V20/69
CPC classification number: G06T7/0012 , G06K9/6228 , G06K9/6257 , G06K9/6267 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/003 , G06T7/11 , G06V10/25 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US11113812B2
公开(公告)日：2021-09-07
申请号：US16203434
申请日：2018-11-28
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US20190172197A1
公开(公告)日：2019-06-06
申请号：US16203428
申请日：2018-11-28
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
5.发明授权公开(公告)号：US12236595B2
公开(公告)日：2025-02-25
申请号：US18545550
申请日：2023-12-19
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , David S. Paik
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
Patent Agency Ranking
公开(公告)号：US12039765B2
公开(公告)日：2024-07-16
申请号：US18309903
申请日：2023-05-01
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
IPC: G06V10/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/00 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06V10/25 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/0012 , G06T7/11 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US11120312B2
公开(公告)日：2021-09-14
申请号：US16203445
申请日：2018-11-28
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US11087460B2
公开(公告)日：2021-08-10
申请号：US16206454
申请日：2018-11-30
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
IPC: G06K9/00 , G06T7/00 , G06T7/11 , G06N20/00 , G06N3/08 , G06K9/32 , G06T5/00 , G06K9/62 , G06T3/00
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US11071501B2
公开(公告)日：2021-07-27
申请号：US16203440
申请日：2018-11-28
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
IPC: G06K9/00 , A61B5/00 , G06T5/00 , G06T5/20 , G06T11/00 , G06T11/60 , A61B6/00 , G16H30/40 , G06N3/08 , G06T7/00 , A61B5/103 , G16H50/20 , G16H50/50 , G16H10/60 , A61B5/02 , A61B5/055 , A61B8/08 , A61B5/107 , A61B6/03 , A61B5/145
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
10.发明授权公开(公告)号：US10755810B2
公开(公告)日：2020-08-25
申请号：US15237249
申请日：2016-08-15
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Keith A. Moulton , Mary Buckler , Larry Martell , David S. Paik , Xiaonan Ma , Samantha St. Pierre
Abstract: Methods and systems are disclosed for structuring and using information pertinent to in vivo biomarkers, specifically quantitative imaging biomarkers, using semantic web technology for personalized medicine and discovery science. It supports the development and application of statistical evidence at a level of granularity and sophistication more closely tied to the complexity of the disease itself and its underlying biology, including technology linking multiple biological scales, than has previously been eedisclosed. It provides data and computational services to analyze quantitative imaging and non-imaging data, coupled with multi-scale modeling to elucidate pre-symptomatic and clinical disease processes. It may be used to assess technical or analytical performance for its own sake and/or to further annotate the quantitative analysis. It supports statistical hypothesis testing to determine and present analytical performance, determine the clinical relevance and establish to what extent a biomarker is causally rather than coincidentally related in clinical contexts of use.
-
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.02 seconds)
